OMER (Omeros Corp.) Prakiraan volume dodolan

Simbol resmi perusahaan Omeros Corp (OMER)

Omeros Corporation balances its budgets through a diverse pipeline of CNS and inflammatory disease developments, leveraging the defensive qualities of the healthcare sector. This chart of the company's future sales visualizes revenue adaptability, where 0.06 expresses the current metric value. The business benefits from the MASP-2 platform and the development of narsoplimab for the targeted therapy of rare thrombotic pathologies without suppressing general immunity.

Volume dodolan sing dikarepake perusahaan: omeros.com (OMER) kanggo 04.07.2022 - 18.11.2026

omeros.com - rincian analitis lan metrik utama (OMER)

- rega saiki lan proyeksi nilai saham:
Analisis kabeh metrik perusahaan:OMER Omeros Corporation
Produk mawa merek Omeros Corporation

The Omeros Corporation (OMER) ecosystem for complement therapy and the treatment of renal pathologies generates unique market demand that converts directly into future cash flows. This algorithm aggregates fundamental revenue expectations and benchmarks them against market capitalization, allowing the organization to determine the degree of asset undervaluation or the risk of overheating relative to actual business growth rates through prospective sales.

Pesaing langsung

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VYGR (voyagertherapeutics.com)|Dodolan mangsa ngarep perusahaan Neumora Therapeutics (NMRA)|SCLX - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Prakiraan pendapatan perusahaan|CGTX - Dodolan mangsa ngarep perusahaan|IKT (inhibikase.com) - Prakiraan volume dodolan|cassavasciences.com (SAVA) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan ASRT (Assertio Therapeutics)|Dodolan mangsa ngarep perusahaan Coya Therapeutics|Vistagen - Volume dodolan mangsa ngarep perusahaan|ovidrx.com (OVID) - Volume dodolan sing dikarepake perusahaan|Acumen Pharmaceuticals - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan cervomed.com|ATHE: Prakiraan volume dodolan|Clene Inc - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Prakiraan volume pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan RLMD (Relmada Corp)|annovisbio.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan sing dikarepake perusahaan|KLTO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics